Literature DB >> 11982484

Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins.

Howard R Mellor1, James Nolan, Lea Pickering, Mark R Wormald, Frances M Platt, Raymond A Dwek, George W J Fleet, Terry D Butters.   

Abstract

We have reductively alkylated deoxynojirimycin imino sugars using sodium cyanoborohydride to provide an efficient means of generating a series of N-alkylated compounds containing 4-18 carbon side chains. The yields were greater than 90% using a variety of aldehydes of different chain lengths, and after purification were >95% pure using (1)H-NMR. Radiolabelled compounds were prepared using sodium cyanoborotriti-ide to selectively label the first carbon atom in the alkyl chain and used in protein-binding and cell- and tissue-uptake experiments. Protein binding was chain-length-dependent with compounds of intermediate chain length (C(9)-C(12)), demonstrating an equal distribution between the aqueous and protein-bound phase. The extent of cell uptake also increased proportionally with increased chain length in a time-dependent manner. When administered to mice, the longer alkyl-chain compounds showed reduced absorption from the intestine and a marked deposition of compound in the liver and brain, suggesting that the more hydrophobic compounds were poorly cleared by the major tissues. In tissue-culture cells compounds with 8 or fewer carbon atoms were non-toxic and had CC(50) (the concentration at which the number of cells or cell proliferation is reduced by 50%) values greater than 1 mM. Compounds with chain lengths above C(8) showed a chain-length-dependent increase in cytotoxicity. N-alkylated deoxynojirimycins (C(4)-C(18)) were evaluated for their inhibitory effects on ceramide-specific glucosyltransferase and glycoprotein-processing alpha-glucosidase. Increasing the alkyl chain length had little effect on alpha-glucosidase activity, but inhibition of ceramide-specific glucosyltransferase increased 10-fold when C(4) and C(9)-C(18) compounds were compared. Overall these data provide further definition of the molecular features of alkylated imino sugars that influence tissue selectivity and efficacy for cellular enzyme inhibition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982484      PMCID: PMC1222746          DOI: 10.1042/BJ20020466

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Synthesis of radioiodinated 1-deoxy-nojirimycin derivatives: novel glucose analogs.

Authors:  Y Xu; S R Choi; M P Kung; H F Kung
Journal:  Nucl Med Biol       Date:  1999-10       Impact factor: 2.408

2.  High-performance cation-exchange chromatography and pulsed amperometric detection for the separation, detection, and quantitation of N-alkylated imino sugars in biological samples.

Authors:  H R Mellor; A Adam; F M Platt; R A Dwek; T D Butters
Journal:  Anal Biochem       Date:  2000-08-15       Impact factor: 3.365

3.  Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

Authors:  T Cox; R Lachmann; C Hollak; J Aerts; S van Weely; M Hrebícek; F Platt; T Butters; R Dwek; C Moyses; I Gow; D Elstein; A Zimran
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

Review 4.  ABC transporters in lipid transport.

Authors:  P Borst; N Zelcer; A van Helvoort
Journal:  Biochim Biophys Acta       Date:  2000-06-26

Review 5.  Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm.

Authors:  N Abumrad; C Coburn; A Ibrahimi
Journal:  Biochim Biophys Acta       Date:  1999-10-18

6.  Distribution and elimination of the glycosidase inhibitors 1-deoxymannojirimycin and N-methyl-1-deoxynojirimycin in the rat in vivo.

Authors:  E D Faber; R Oosting; J J Neefjes; H L Ploegh; D K Meijer
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

7.  pH gradients across phospholipid membranes caused by fast flip-flop of un-ionized fatty acids.

Authors:  F Kamp; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.

Authors:  F M Platt; G R Neises; R A Dwek; T D Butters
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

9.  The antiglycogenolytic action of 1-deoxynojirimycin results from a specific inhibition of the alpha-1,6-glucosidase activity of the debranching enzyme.

Authors:  M Bollen; W Stalmans
Journal:  Eur J Biochem       Date:  1989-05-15

10.  The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3.

Authors:  M A Fischl; L Resnick; R Coombs; A B Kremer; J C Pottage; R J Fass; K H Fife; W G Powderly; A C Collier; R L Aspinall
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-02
View more
  17 in total

1.  Alkyl chain modulated cytotoxicity and antioxidant activity of bioinspired amphiphilic selenolanes.

Authors:  Prachi Verma; Amit Kunwar; Kenta Arai; Michio Iwaoka; K Indira Priyadarsini
Journal:  Toxicol Res (Camb)       Date:  2015-11-25       Impact factor: 3.524

2.  Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars.

Authors:  Amar Ghisaidoobe; Pieter Bikker; Arjan C J de Bruijn; Frithjof D Godschalk; Eva Rogaar; Marieke C Guijt; Peter Hagens; Jerre M Halma; Steven M Van't Hart; Stijn B Luitjens; Vincent H S van Rixel; Mark Wijzenbroek; Thor Zweegers; Wilma E Donker-Koopman; Anneke Strijland; Rolf Boot; Gijs van der Marel; Herman S Overkleeft; Johannes M F G Aerts; Richard J B H N van den Berg
Journal:  ACS Med Chem Lett       Date:  2010-12-02       Impact factor: 4.345

3.  Small-molecule-based inhibition of histone demethylation in cells assessed by quantitative mass spectrometry.

Authors:  Mukram M Mackeen; Holger B Kramer; Kai-Hsuan Chang; Matthew L Coleman; Richard J Hopkinson; Christopher J Schofield; Benedikt M Kessler
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

4.  Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.

Authors:  Howard R Mellor; Frances M Platt; Raymond A Dwek; Terry D Butters
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

Review 5.  Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation.

Authors:  Aarnoud C van der Spoel; Richard Mott; Frances M Platt
Journal:  Pharmacogenomics       Date:  2008-06       Impact factor: 2.533

6.  Cellular effects of deoxynojirimycin analogues: inhibition of N-linked oligosaccharide processing and generation of free glucosylated oligosaccharides.

Authors:  Howard R Mellor; David C A Neville; David J Harvey; Frances M Platt; Raymond A Dwek; Terry D Butters
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

7.  Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis.

Authors:  Howard R Mellor; David C A Neville; David J Harvey; Frances M Platt; Raymond A Dwek; Terry D Butters
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

8.  Cytotoxicity and enzymatic activity inhibition in cell lines treated with novel iminosugar derivatives.

Authors:  Mercè Padró; José A Castillo; Livia Gómez; Jesús Joglar; Pere Clapés; Carme de Bolós
Journal:  Glycoconj J       Date:  2009-12-30       Impact factor: 2.916

Review 9.  Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.

Authors:  Terry D Butters; Howard R Mellor; Keishi Narita; Raymond A Dwek; Frances M Platt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

10.  The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study.

Authors:  Wilhelm Bone; Charlotte M Walden; Martin Fritsch; Ulrike Voigtmann; Eckhard Leifke; Ulrich Gottwald; Stephanie Boomkamp; Frances M Platt; Aarnoud C van der Spoel
Journal:  Reprod Biol Endocrinol       Date:  2007-01-22       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.